Eyelid Merkel cell carcinoma in a patient treated with golimumab

H Hanafi, R M Verdijk, D Paridaens

Onderzoeksoutput: Bijdrage aan tijdschriftBriefpeer review


PURPOSE: To describe a clinical case of biopsy-proven Merkel cell carcinoma of the eyelid following golimumab therapy for rheumatoid arthritis (RA).

METHODS: Interventional case report.

RESULTS: A 73-year-old woman with a history of chronic RA presented with a right upper eyelid mass. She had been treated with golimumab (tumor necrosis factor (TNF) inhibitors) injection therapy for the past 6 months. A biopsy showed findings suggestive of a Merkel cell carcinoma of the eyelid.

CONCLUSIONS: Merkel cell carcinoma may be associated with anti-TNF treatment and should be included in the differential diagnosis of an eyelid tumor in patients treated with TNF inhibitors.

Originele taal-2Engels
Pagina's (van-tot)21-25
Aantal pagina's5
TijdschriftOrbit (Amsterdam, Netherlands)
Nummer van het tijdschrift1
StatusGepubliceerd - feb. 2018


Duik in de onderzoeksthema's van 'Eyelid Merkel cell carcinoma in a patient treated with golimumab'. Samen vormen ze een unieke vingerafdruk.

Citeer dit